MX2015011722A - Proceso para la preparacion de (2s, 5r)-7-oxo-6-sulfooxi-2-[((3r)- piperidin-3-carbonil)carbonil hidrazino]-1,6-diaza-biciclo[3.2.1] octano. - Google Patents

Proceso para la preparacion de (2s, 5r)-7-oxo-6-sulfooxi-2-[((3r)- piperidin-3-carbonil)carbonil hidrazino]-1,6-diaza-biciclo[3.2.1] octano.

Info

Publication number
MX2015011722A
MX2015011722A MX2015011722A MX2015011722A MX2015011722A MX 2015011722 A MX2015011722 A MX 2015011722A MX 2015011722 A MX2015011722 A MX 2015011722A MX 2015011722 A MX2015011722 A MX 2015011722A MX 2015011722 A MX2015011722 A MX 2015011722A
Authority
MX
Mexico
Prior art keywords
carbonyl
sulphooxy
diaza
bicyclo
octane
Prior art date
Application number
MX2015011722A
Other languages
English (en)
Inventor
Mahesh Vithalbhai Patel
Prasad Keshav Deshpande
Sanjeev Joshi
Shivaji Sampatrao Pawar
Sunil Bhaginath Jadhav
Karuna Suresh Wankhede
Satish Bhawsar
Ravindra Dattatraya Yeole
Vinod Kashinath Ahirrao
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority claimed from PCT/IB2013/059326 external-priority patent/WO2014135931A1/en
Publication of MX2015011722A publication Critical patent/MX2015011722A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describe un procedimiento para la preparación de (2S, 5R)-7-oxo-6-sulfoxi-2- [((3R) -piperidin-3-carbonil) carbonil) hidrazino] -1,6-diaza-biciclo [3.2.1] octano.
MX2015011722A 2013-03-08 2013-10-12 Proceso para la preparacion de (2s, 5r)-7-oxo-6-sulfooxi-2-[((3r)- piperidin-3-carbonil)carbonil hidrazino]-1,6-diaza-biciclo[3.2.1] octano. MX2015011722A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN717MU2013 2013-03-08
PCT/IB2013/059326 WO2014135931A1 (en) 2013-03-08 2013-10-12 A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane

Publications (1)

Publication Number Publication Date
MX2015011722A true MX2015011722A (es) 2015-12-03

Family

ID=54250566

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011722A MX2015011722A (es) 2013-03-08 2013-10-12 Proceso para la preparacion de (2s, 5r)-7-oxo-6-sulfooxi-2-[((3r)- piperidin-3-carbonil)carbonil hidrazino]-1,6-diaza-biciclo[3.2.1] octano.

Country Status (10)

Country Link
US (2) US9657021B2 (es)
JP (2) JP6285969B2 (es)
CN (2) CN105143225A (es)
AU (1) AU2013380574B2 (es)
BR (1) BR112015021393A2 (es)
CA (1) CA2904079C (es)
MX (1) MX2015011722A (es)
NZ (1) NZ711327A (es)
RU (1) RU2627700C2 (es)
ZA (1) ZA201506483B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3013829A1 (en) * 2013-03-08 2016-05-04 Wockhardt Limited A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
CA2904084C (en) * 2013-03-08 2017-03-28 Wockhardt Limited A process for preparation of (2s, 5r)- sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
JP6285969B2 (ja) * 2013-03-08 2018-02-28 ウォックハート リミテッド （２ｓ，５ｒ）−７−オキソ−６−スルホオキシ−２−［（（３ｒ）−ピペリジン−３−カルボニル）−ヒドラジノカルボニル］−１，６−ジアザ−ビシクロ［３．２．１］オクタンの調製のためのプロセス
BR112019015834A2 (pt) * 2017-02-06 2020-03-31 Mutabilis Compostos, composição farmacêutica, kit e uso de um composto ou uma composição

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9408450A (pt) * 1993-12-29 1997-08-05 Pfizer Antagonistas da neuroquinina diazabiciclicos
FR2740136B1 (fr) * 1995-10-24 1998-01-09 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MY162532A (en) * 2008-01-18 2017-06-15 Merck Sharp & Dohme Beta-lactamase inhibitors
JP2011160817A (ja) * 2010-02-04 2011-08-25 Univ Of Tokyo 移植支援材料
CA2822758C (en) 2010-12-22 2018-03-20 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
MX348974B (es) * 2011-08-27 2017-07-04 Wockhardt Ltd Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
JP6285969B2 (ja) * 2013-03-08 2018-02-28 ウォックハート リミテッド （２ｓ，５ｒ）−７−オキソ−６−スルホオキシ−２−［（（３ｒ）−ピペリジン−３−カルボニル）−ヒドラジノカルボニル］−１，６−ジアザ−ビシクロ［３．２．１］オクタンの調製のためのプロセス
WO2015110885A1 (en) 2014-01-21 2015-07-30 Wockhardt Limited A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane

Also Published As

Publication number Publication date
US9834557B2 (en) 2017-12-05
AU2013380574B2 (en) 2016-07-07
CA2904079A1 (en) 2014-09-12
AU2013380574A1 (en) 2015-09-10
CA2904079C (en) 2017-09-19
US20160002235A1 (en) 2016-01-07
RU2015142580A (ru) 2017-04-20
JP2018080180A (ja) 2018-05-24
NZ711327A (en) 2016-06-24
RU2627700C2 (ru) 2017-08-10
JP6285969B2 (ja) 2018-02-28
US9657021B2 (en) 2017-05-23
JP2016514107A (ja) 2016-05-19
BR112015021393A2 (pt) 2017-07-18
US20170197963A1 (en) 2017-07-13
CN108191864A (zh) 2018-06-22
CN105143225A (zh) 2015-12-09
ZA201506483B (en) 2016-12-21

Similar Documents

Publication Publication Date Title
AU2013380573A8 (en) A process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
MX350892B (es) Síntesis de compuesto antiviral.
SG195289A1 (en) Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
CO6831982A2 (es) Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
MX348654B (es) Composicion farmaceutica con biodisponibilidad mejorada para compuesto hidrofobico de alto punto de fusion.
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
IN2014MN01521A (es)
NZ711327A (en) A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane
IN2014DN00144A (es)
MY157423A (en) Production method of intermediate compound for synthesizing medicament
WO2014087208A3 (en) A process of preparing alcaftadine
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
MX2015011721A (es) Proceso para la preparacion de (2s,5r) -7-oxo-6-sulfooxi-2-[((3r)- pirrolidin-3-carbonil) carbonil hidrazino]-1,6-diaza-biciclo[3.2.1 ] octano.
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX2016012648A (es) Proceso para la preparacion de (2s,5r)-6-(benciloxi)-7-oxo-1,6-dia zabiciclo[3.2.1]octano-2-carboxilato de sodio.
IN2014DN09451A (es)
NZ711329A (en) A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
MX363944B (es) Método de preparación de los compuestos de ceramidas de alfa-galactosilo.
WO2015079329A3 (en) Polymorphs and process for pretaration of (2s,5r)-7-0x0-n-[(2s)-pyrrollidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1 ]octane-2-carboxamide
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
WO2014060575A3 (en) Process for the enantioselective synthesis of a tetrahydrobenzazepine compound
WO2014061036A3 (en) Tetraoxa diphosphaspiro compounds
MX2013004425A (es) Preparacion diastereoselectiva de los compuestos de biciclo [2.2.2] octan-2-ona.
IN2015DN01414A (es)